Cargando…
Taurochenodeoxycholic Acid Inhibited AP-1 Activation via Stimulating Glucocorticoid Receptor
Taurochenodeoxycholic acid (TCDCA) as a primary bioactive substance of animal bile has been shown to exert good anti-inflammatory and immunomodulatory functions in adjuvant arthritis in rats. The anti-inflammatory and immunomodulatory properties of TCDCA have exhibited interesting similarities with...
Autores principales: | Li, Lei, Liu, Chang, Mao, Wei, Tumen, Bayaer, Li, Peifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943563/ https://www.ncbi.nlm.nih.gov/pubmed/31835494 http://dx.doi.org/10.3390/molecules24244513 |
Ejemplares similares
-
Transcriptome investigation of anti‐inflammation and immuno‐regulation mechanism of taurochenodeoxycholic acid
por: Bao, Lige, et al.
Publicado: (2021) -
Taurochenodeoxycholic Acid Increases cAMP Content via Specially Interacting with Bile Acid Receptor TGR5
por: Qi, Youchao, et al.
Publicado: (2021) -
Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma
por: Song, Won-Suk, et al.
Publicado: (2018) -
Metabolomic and lipidomic studies on the intervention of taurochenodeoxycholic acid in mice with hyperlipidemia
por: Cui, Na, et al.
Publicado: (2023) -
Small intestinal taurochenodeoxycholic acid-FXR axis alters local nutrient-sensing glucoregulatory pathways in rats
por: Waise, T.M. Zaved, et al.
Publicado: (2020)